CME Group Inc (CME) Stock: Analyzing the Market Value

Biotech Stocks to buy

CME Group Inc (NASDAQ: CME) has a higher price-to-earnings ratio of 23.91x compared to its average ratio, The 36-month beta value for CME is at 0.56. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 4 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”

The public float for CME is 358.87M, and currently, shorts hold a 1.01% of that float. The average trading volume for CME on October 31, 2024 was 1.85M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CME) stock’s latest price update

CME Group Inc (NASDAQ: CME) has experienced a rise in its stock price by 0.07 compared to its previous closing price of 227.09. However, the company has seen a gain of 0.05% in its stock price over the last five trading days. zacks.com reported 2024-10-29 that Stocks like IBKR, CME, ACN and BLK are poised to benefit from the ongoing Bitcoin rally.

CME’s Market Performance

CME’s stock has risen by 0.05% in the past week, with a monthly rise of 0.88% and a quarterly rise of 15.77%. The volatility ratio for the week is 1.42% while the volatility levels for the last 30 days are 1.45% for CME Group Inc. The simple moving average for the past 20 days is 0.85% for CME’s stock, with a 8.14% simple moving average for the past 200 days.

Analysts’ Opinion of CME

Many brokerage firms have already submitted their reports for CME stocks, with Redburn Atlantic repeating the rating for CME by listing it as a “Neutral.” The predicted price for CME in the upcoming period, according to Redburn Atlantic is $244 based on the research report published on October 08, 2024 of the current year 2024.

RBC Capital Mkts, on the other hand, stated in their research note that they expect to see CME reach a price target of $235. The rating they have provided for CME stocks is “Sector Perform” according to the report published on September 27th, 2024.

TD Cowen gave a rating of “Hold” to CME, setting the target price at $221 in the report published on September 26th of the current year.

CME Trading at 3.34% from the 50-Day Moving Average

After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.35% of loss for the given period.

Volatility was left at 1.45%, however, over the last 30 days, the volatility rate increased by 1.42%, as shares surge +1.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.89% upper at present.

During the last 5 trading sessions, CME rose by +0.05%, which changed the moving average for the period of 200-days by +14.43% in comparison to the 20-day moving average, which settled at $225.35. In addition, CME Group Inc saw 7.91% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CME starting from Cutinho Sunil, who sale 4,500 shares at the price of $226.64 back on Oct 30 ’24. After this action, Cutinho Sunil now owns 27,053 shares of CME Group Inc, valued at $1,019,879 using the latest closing price.

Bitsberger Timothy S., the Director of CME Group Inc, sale 1,000 shares at $226.96 during a trade that took place back on Oct 30 ’24, which means that Bitsberger Timothy S. is holding 10,589 shares at $226,957 based on the most recent closing price.

Stock Fundamentals for CME

Current profitability levels for the company are sitting at:

  • 0.64 for the present operating margin
  • 0.78 for the gross margin

The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.1. Equity return is now at value 12.28, with 2.63 for asset returns.

Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.04. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is 96.92.

Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.27. When we switch over and look at the enterprise to sales, we see a ratio of 13.72. The receivables turnover for the company is 9.6for trailing twelve months and the total asset turnover is 0.04.

Conclusion

In conclusion, CME Group Inc (CME) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts